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Background: While factors associated with health-related quality of life for people with chronic diseases including
diabetes are well researched, far fewer studies have investigated measures of disease-specific quality of life. The
purpose of this study is to assess the impact of complications and comorbidities on diabetes-specific quality of life
in a large population-based cohort of type 2 diabetic patients.
Methods: The Living with Diabetes Study recruited participants from the National Diabetes Services Scheme in
Australia. Data were collected via a mailed self-report questionnaire. Diabetes-specific quality of life was measured
using the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire. The analyses are for 3609 patients
with type 2 diabetes. Regression models with adjustment for control variables investigated the association of
complications and comorbidities with diabetes-specific quality of life. Next, the most parsimonious model for
diabetes-specific quality of life after controlling for important covariates was examined.
Results: The expected associations with better diabetes-specific quality of life were evident, such as increased
income, not on insulin, better glycaemic control and older age. However, being single and having been diagnosed
with cancer were also associated with better ADDQoL. Additionally, poorer diabetes-specific quality of life was
strongly sensitive to the presence of diabetes complications and mental health conditions such as depression,
anxiety and schizophrenia. These relationships persisted after adjustment for gender, age, duration of diabetes,
treatment regimen, sampling region and other treatment and socio-demographic variables.
Conclusions: A greater appreciation of the complexities of diabetes-specific quality of life can help tailor disease
management and self-care messages given to patients. Attention to mental health issues may be as important as
focusing on glycaemic control and complications. Therefore clinicians’ ability to identify and mange mental health
issues and/or refer patients is critical to improving patients’ diabetes-specific quality of life.
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AdultsBackground
Diabetes mellitus currently affects about 285 million
adults worldwide, with this figure expected to rise to 439
million adults by 2030 [1]. The day-to-day medical man-
agement of diabetes for the rapidly increasing number of
people diagnosed with the disease is demanding both* Correspondence: m.donald@sph.uq.edu.au
School of Population Health, University of Queensland, Herston Campus,
Brisbane, Queensland, Australia
© 2013 Donald et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orphysically and emotionally and can have an adverse impact
on patients’ quality of life [2,3]. Diabetes affects many
areas of life, such as diet, employment and leisure. More-
over, the chronic nature of diabetes means that the im-
pacts of the disease may be experienced for many years
and its management and treatment can be complex and
time consuming. The forecast scale of the epidemic,
coupled with the nature of the illness, give good reason toLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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quality of life.
Researchers have underlined the importance of dis-
tinguishing between health-related quality of life, quality
of life, and disease-specific quality of life [4,5]. Health-
related quality of life measures a patient’s symptoms and
functioning, including dimensions such as mobility, pain,
or a patient’s ability to care for themself or engage in usual
daily activities. Quality of life, on the other hand, is a
broad concept encompassing health, but also a person’s
values, aspirations, recreational pursuits and interpersonal
relationships [6]. Disease-specific quality of life also cap-
tures these non-health related aspects of a person’s life but
also relates to those aspects directly impacted by the dis-
ease. For example in the case of diabetes this includes fea-
tures such as dietary restrictions, the ability to maintain a
working life or to travel despite the inherent complexities
of managing diabetes. Disease-specific quality of life mea-
sures are generally sensitive to the specific disease’s treat-
ments and complications [7].
A number of disease-specific quality of life measures
designed for people with diabetes mellitus have been de-
veloped in recent years. Of these, several have been found
to have good psychometric properties [7,8], including the
Audit of Diabetes-Dependent Quality of Life (ADDQoL)
questionnaire [9,10]. Despite recognition of diabetes-
specific quality of life as a useful patient reported outcome,
as well as numerous studies designed to investigate the
psychometric properties of the ADDQoL [11-13], little
work has been done to investigate the factors associated
with diabetes-specific quality of life in large scale epi-
demiological studies.
Sundaram and colleagues (2009) have emphasised the
need to strengthen the understanding of the impact of
various disease and treatment characteristics, and comor-
bid conditions, on diabetes-specific quality of life, espe-
cially as distinguished from health-related quality of life. In
one of the few descriptive studies to investigate diabetes-
specific quality of life, relying on a small clinic-based con-
venience sample, it was found that diabetes-specific quality
of life was associated with insulin use, glycaemic control,
the number of diabetes-related complications and depres-
sive symptomatology, but not obesity [5]. Furthermore, pre-
vious research has shown that diabetes-specific quality of
life as measured by the ADDQoL distinguishes between in-
sulin treated and non-insulin treated patients, and is sensi-
tive to the presence of diabetes complications [9] but is
unaffected by comorbidity unrelated to diabetes [14]. This
pattern of associations is consistent with the tenets of
disease-specific quality of life measures. However, no
study has had a large enough sample size to evaluate
individual diabetes complications and comorbidities
rather than a simple count, or to test associations
using multivariable models.The purpose of the present study was to assess the
diabetes-specific quality of life of a large sample of patients
with type 2 diabetes. Specific objectives included: (1) to as-
sess which individual diabetes complications are associ-
ated with diabetes-specific quality of life among patients
with type 2 diabetes; (2) to assess which, if any, individual
comorbidities are associated with diabetes-specific quality
of life among patients with type 2 diabetes; and (3) to use
a multivariable framework to identify factors independ-
ently associated with diabetes-specific quality of life.
Methods
Study design
Data reported are from the Living with Diabetes Study, a
longitudinal study conducted in the State of Queensland,
Australia. Data were collected annually, from 2008
through 2011, via a mailed self-report questionnaire. This
paper reports on a cross-sectional analysis of the 2008
baseline data. Details of the methods, baseline characteris-
tics and generalizability of the sample are published else-
where [15,16].
Participants
Participants were recruited from the National Diabetes
Services Scheme (NDSS), an initiative of the Australian
Government administered by Diabetes Australia. It is esti-
mated that the NDSS covers 80% to 90% of the Australian
population diagnosed with diabetes [17]. People were eli-
gible to participate in the study if they were aged 18 years
or older and had physician-diagnosed type 1 or type 2 dia-
betes. The study oversampled in three areas of policy
interest: an outer metropolitan area, a new suburban de-
velopment and a coastal agricultural community (all ana-
lyses are adjusted for this region-based sampling scheme).
A sample of 14439 registrants of the NDSS was invited to
participate at baseline in 2008. Completed questionnaires
were returned by 3951 participants, yielding a participa-
tion rate of 29% after notified deaths and returns to sender
were omitted. Ninety-five percent (n=3761) of the Living
with Diabetes Study participants had a diagnosis of type 2
diabetes.
Ethics approval for the study was granted by the Univer-
sity of Queensland’s Behavioural and Social Sciences Eth-
ical Review Committee. Written informed consent was
obtained from all study participants.
Measuring diabetes-specific quality of life
The ADDQoL includes two global items; one assesses
generic or “present” overall quality of life (measured on
a seven point scale: range −3 to +3) and the second as-
sesses diabetes-specific quality of life (measured on a five
point scale: range −3 to +1) [9,10]. For both items lower
scores reflect poorer quality of life. The ADDQoL also
examines the impact of diabetes on 19 specific aspects
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ily/relatives, close personal relationship and sex life) re-
spondents may indicate that the domain does not apply
to them and the domain score is set to missing. The
ADDQoL allows participants to rate the impact of dia-
betes (positive or negative) on each domain, as well as
rate the importance of that domain for their quality of
life. The impact score is then multiplied by the import-
ance rating to yield a weighted impact score for each do-
main (range −9 to +3). An average weighted impact
(AWI) score is also calculated for the entire scale by aver-
aging across all applicable domains. In this case, the AWI
score was not calculated for 140 respondents due to miss-
ing data in 10 or more of the 19 domains.
Several recent reviews of diabetes-specific quality of life
instruments conclude that there is good evidence that the
ADDQoL is reliable with good face and content validity
[7,8,18]. The psychometric properties of the ADDQoL for
the Living with Diabetes Study have been published previ-
ously and showed that all 19 domains loaded above 0.4
using a forced principal components analysis with a vari-
max rotation and internal consistency reliability was excel-
lent with a Chronbach’s alpha value of 0.95 [19].
Complications and comorbidities
The participants were asked to indicate with which of the
above, if any, they had ever been diagnosed. Diabetes com-
plications measured were the presence or absence of any
of the following: eye disease, kidney disease, nerve damage
or neuropathy, heart disease, stroke or transient ischemic
attack, erectile dysfunction, poor circulation, foot ulcers,
and gangrene or amputation. Participants were also pro-
vided with a list of comorbidities not directly related to dia-
betes (i.e. those that do not share the same pathogenesis or
treatment approach as diabetes), including asthma, chronic
obstructive pulmonary disease, arthritis, dementia, schizo-
phrenia or psychosis, bipolar disorder/manic-depression,
depression, anxiety, substance use disorder, osteoporosis,
malignant melanoma, and non-melanoma cancers (lung,
prostate, breast, or other).
Other relevant covariates
After considering the literature on diabetes-specific quality
of life, as well as the measures collected in the Living with
Diabetes Study, the following variables were examined in
addition to the complications and comorbidities in this
paper. Patient socio-demographic characteristics included
their gender, age, marital status (i.e. never married, mar-
ried or living with a partner, and secondarily single), and
annual household income. Diabetes related covariates in-
cluded a self-reported measure of glycaemic control (col-
lected by asking patients the result of their most recent
HbA1c test), insulin treatment status and the duration of
their diabetes. Body mass index (BMI) was measured byasking patients their weight and height. Only 12 study par-
ticipants reported a BMI in the underweight range and
were excluded from these analyses.
Statistical analysis
The first step in the analysis was to summarise the means
and medians to determine the impact of diabetes on each
of the 19 ADDQoL domains. The next step was to deter-
mine the association between diabetes-specific quality of
life as measured by the ADDQoL AWI score and each
diabetes complication and comorbid condition separately.
Each complication was entered into a regression model
that included five control variables, namely gender, age,
duration of diabetes, treatment regimen and sampling re-
gion. Each comorbidity was also assessed using the same
control variables. Results of these partially adjusted models
for complications and comorbidities are presented as least
squares means in radar plots.
To determine which factors were independently asso-
ciated with the outcome, a multiple linear regression
with a backward-elimination selection procedure was
used. Candidates for inclusion in the model were the
total number of complications, those comorbidities that
were significant in the partially adjusted models as well
as other variables thought to be plausibly associated
with the outcome. The count of diabetic complications
was used rather than each individual complication to re-
duce the chance of multicollinearity due to associations
among the various complications. This is not the case
for comorbidities where each illness is not related to the
others and an association with diabetes-specific quality
of life was not expected. As control variables, sampling
region, gender, age, duration of diabetes and treatment
regimen were forced into the model regardless of their
statistical significance. For all other variables, the cri-
teria for a factor staying in the model was set to p<0.05.
Results of the multiple linear regression are presented
as least squares means with 95% confidence limits. All
analyses were conducted using SAS Version 9.3.
Results
Characteristics of respondents
The analyses reported here are for 3609 patients with type
2 diabetes. Forty-four percent (n=1594) of the participants
were female. Participants’ age ranged from 22 to 94 years,
with an overall mean age of 62.2 years. The mean age of
men (63.3 years, 95% CI 62.9-63.8) was significantly
greater (p<0.001) than that of women (60.8 years, 95% CI
60.3-61.4). The majority of participants (approximately
62%) were not employed, with 45% reporting that they
had retired. While 13.3% of participants had completed
university study, 47.5% reported education to year 10 or
below. 1.7% of the sample identified themselves as being
Aboriginal or Torres Strait Islander Australians.
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years. On average, 7.4 years had elapsed since the date of
diabetes diagnosis. Approximately 18% of participants
(n=659) required insulin to treat their diabetes (either
alone or in combination with oral medications), 61% re-
quired glucose-lowering tablets (n=2196) and 21% treated
their diabetes with diet and/or exercise alone (n=753).
Diabetes-specific quality of life
The mean AWI score for the sample was −1.59 (n=3609;
SD=1.75; range −9 to 1). The mean for the generic qual-
ity of life item was +1.09 (n=3589; SD=0.98; range −3 to
3) and the mean for the generic diabetes quality of life
item was −1.07 (n=3587; SD=0.98; range −3 to 1). Over-
all, all 19 domains were negatively impacted by the pres-
ence of diabetes. However examination of the medians
showed only 5 domains to be negatively impacted. Free-
dom to eat as desired was the most impacted aspect of
life, and perception regarding the way others react to
participants was the least impacted domain (Table 1).
The relationship between diabetes complications,
comorbidities and diabetes-specific quality of life
Each of the diabetes complications (with the exception of
gangrene/amputation) was significantly associated with
diabetes-specific quality of life in the partially-adjustedTable 1 Impact of type 2 diabetes on each of the 19
domains of the ADDQoL
Domain Weighted impact score
N Mean (SD) Median (IQR)
Freedom to eat 3586 −2.74(2.85) −2(−4,0)
Sex life 2815 −2.33(2.99) 0(−4,0)
Feelings about future 3529 −2.20(2.86) −1(−4,0)
Personal relationship 3144 −2.01(2.87) 0(−3,0)
Freedom to drink 3595 −1.83(2.51) −1(−3,0)
Work life 1560 −1.78(2.49) 0(−3,0)
Holidays 3044 −1.73(2.40) 0(−3,0)
Physical ability 3427 −1.71(2.31) −1(−3,0)
Family/relatives 3457 −1.68(2.55) 0(−3,0)
Motivation levels 3536 −1.66(2.59) 0(−3,0)
Leisure activities 3421 −1.65(2.22) −1(−2,0)
Friendships and social life 3508 −1.37(2.25) 0(−2,0)
Financial situation 3552 −1.37(2.38) 0(−2,0)
Travel 3487 −1.33(2.13) 0(−2,0)
Self-confidence 3524 −1.30(2.35) 0(−2,0)
Physical appearance 3509 −1.24(2.27) 0(−2,0)
Dependent on others 3459 −1.13(2.38) 0(−1,0)
Living conditions 3560 −1.07(2.20) 0(−1,0)
People’s reaction to me 3578 −0.57(1.61) 0(0,0)analyses (Figure 1). Although there was a sizable difference
in the AWI score between participants with and without a
history of gangrene and/or amputation, the difference was
not significant, likely due to the small number of partici-
pants with this condition. The partially adjusted analyses
for the comorbidities showed a history of mental health is-
sues (depression, anxiety, schizophrenia) as well as arthritis,
COPD and asthma were associated with poorer diabetes-
specific quality of life, while a history of cancer (non-melan-
oma) was associated with better diabetes-specific quality of
life (Figure 2).
Final multivariable model for diabetes-specific quality of life
The final regression model was significant (F=24.3;
P<.0001) and explained 19% (adjusted R2) of the variance
in diabetes-specific quality of life. A significant gradient
was observed for the number of complications and
diabetes-specific quality of life. Mental health issues were
retained in the model, diabetic patients with a history of
such problems reported poorer diabetes-specific quality of
life (Table 2). Interestingly, a history of cancer was associ-
ated with better diabetes-specific quality of life. Other sig-
nificant socio-demographic and diabetes related factors
associated with better diabetes-specific quality of life in-
cluded higher income, never having been married, gly-
caemic control, age and treatment status.
Discussion
Diabetes has the greatest overall negative impact on pa-
tients’ freedom to eat as they wish, and the least negative
impact on their perception concerning the way others in
society react to them. The negative impact that the loss
of dietary flexibility has on patients’ diabetes-specific
quality of life is of particular interest given the ubiqui-
tous nature of this finding across different contexts and
research studies [10-13]. It likely refers not only to diet-
ary restrictions around healthful eating and weight loss
but also the need to regularly monitor the relationship
between food intake, energy expenditure and blood glu-
cose levels. This poses something of a challenge to the
way the management of type 2 diabetes is undertaken
because while dietary change may help delay outcomes
associated with poorer quality of life such as disease pro-
gression and the onset of diabetes complications [20,21],
it is itself associated with decreased quality of life. One
method available to health care providers to encourage
good self-care among diabetic patients is to emphasise the
increased potential for developing diabetes complications
with poor diet and poor glycaemic control. However, un-
due emphasis on this association may be counterproduct-
ive and could result in a negative impact on self-care and
consequently glycaemic control [22].
Indeed, our study has confirmed that diabetes complica-


























Figure 1 Diabetes-specific quality of life according to the presence or absence of diabetes complications. Results are expressed as
least-square means. Yes = Has ever been told by a doctor or nurse that they have the condition. Analysis included only men for erectile
dysfunction, *p <0.05 after adjustment for sampling region, sex, age, duration of diabetes and treatment regimen, n = the number of
participants with the condition.
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likelihood of patients reporting a lower diabetes-specific
quality of life. Moreover, each additional complication fur-
ther reduced diabetes-specific quality of life even after
controlling for other important covariates. Unlike compli-
cations however, the presence of comorbidities does not
influence diabetes-specific quality of life after controlling
for relevant covariates. The clear exceptions were mental
health issues and cancer. The former confirms previous
reports [23].
Perhaps these mental health problems impact on disease
management, and in particular a patient’s capacity for self-
care more so than the physically orientated comorbidities.
There is evidence to suggest that depression is associated
with a decrease in some self-care behaviours [24,25]. Al-
ternatively, symptoms of anxiety and depression adversely















Figure 2 Diabetes-specific quality of life according to the presence or
means, Yes = Has ever been told by a doctor or nurse that they have the c
after adjustment for sampling region, sex, age, duration of diabetes and trelower the quality of life of those with diabetes [26]. There
is accumulating evidence to suggest that diabetes, depres-
sion and quality of life are closely interrelated and that dia-
betes is causally related to depression and vice versa [27].
Whether depression and anxiety should be considered
complications of diabetes rather than comorbidities is of
interest. In either case, it is clear that additional attention
must be paid to diabetic patients with mental health issues
such as anxiety and depression in order to ensure that
they enjoy a quality of life comparable to that of those
without these mental health problems. Improvements to
both quality of life and disease management could be
achieved by improving the identification and management
of mental health problems among people with diabetes
[2,23].
Also of interest in relation to comorbidities was the find-











absence of comorbidities. Results are expressed as least-square
ondition, COPD = Chronic Obstructive Pulmonary Disease, *p <0.05
atment regimen, n = the number of participants with the condition.
Table 2 Final multivariable regression model for
diabetes-specific quality of life













0 1579 (46.1) −1.25 −1.33 −1.17
1 828 (24.2) −1.56 −1.66 −1.45
2 518 (15.1) −1.92 −2.06 −1.78
3 284 (8.3) −2.17 −2.36 −1.98
4 or more 215 (6.3) −2.50 −2.72 −2.27
Depression 0.001
No 2615 (76.4) −1.53 −1.59 −1.47
Yes 809 (23.6) −1.75 −1.87 −1.64
Anxiety <0.001
No 3081 (90.0) −1.54 −1.59 −1.48
Yes 343 (10.0) −1.97 −2.15 −1.79
Schizophrenia 0.016
No 3405 (99.5) −1.58 −1.63 −1.52




No 3107 (90.7) −1.60 −1.66 −1.55







<$20 K 925 (27.2) −1.82 −1.93 −1.71
20 K – 40 K 863 (25.2) −1.50 −1.61 −1.39
40 K – 80 K 772 (22.6) −1.42 −1.53 −1.30
80 K – 120 K 309 (9.0) −1.36 −1.54 −1.17
120 K – 160 K 108 (3.2) −1.25 −1.55 −0.95
>160 K 67 (2.0) −0.91 −1.30 −0.53
Missing/do not
know
380 (11.1) −1.92 −2.08 −1.76
Marital status 0.018
Never married 208 (6.1) −1.32 −1.54 −1.09
Co-habiting 2450 (71.6) −1.62 −1.69 −1.56
Secondarily
single
766 (22.4) −1.52 −1.64 −1.40
HbA1c result <0.001
Under 6.5% 796 (23.3) −1.38 −1.49 −1.27
6.5% - 7.0% 891 (26.0) −1.57 −1.67 −1.46
7.1% - 8.0% 746 (21.8) −1.62 −1.73 −1.50
Table 2 Final multivariable regression model for diabetes-
specific quality of life (Continued)
Over 8.0% 453 (13.2) −1.95 −2.10 −1.80
Do not know 538 (15.7) −1.55 −1.68 −1.41
Age quartile <0.001
Q1: 22–55 y 858 (25.1) −2.07 −2.18 −1.95
Q2: 56–62 y 871 (25.4) −1.67 −1.78 −1.56
Q3: 63–69 y 877 (25.6) −1.43 −1.53 −1.32




630 (18.4) −2.01 −2.15 −1.88
Oral
medications
2078 (60.7) −1.58 −1.64 −1.51
Diet and/or
exercise only
716 (20.9) −1.22 −1.34 −1.10
Model is adjusted for the five control variables: Age and treatment status were
significant; sampling region, sex and duration of diabetes were non-significant
and are not shown.
a185 participants (5.1%) had missing data for one or more covariates and are
not included in this analysis.
bincludes eye disease, kidney disease, nerve damage or neuropathy, heart
disease, stroke or transient ischemic attack, erectile dysfunction, poor
circulation, foot ulcers, and gangrene or amputation.
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population. Previous research has shown that individuals
with diabetes and cancer have a significantly lower health-
related quality of life than those with either condition alone
[28]. The findings reported here are not incompatible with
this but instead reinforce the importance of distinguishing
between health-related quality of life and disease-specific
quality of life. The finding most likely reflects the fact that
our diabetic cancer survivors rated their diabetes-specific
quality of life as better than their non-cancer peers because
cancer-specific decreases in health status are not attributed
to diabetes and/or the adverse impact of cancer-specific
characteristics on quality of life outweigh those related to
diabetes.
The finding that better metabolic control was associated
with better diabetes-specific quality of life independent of
complications suggests that efforts to achieve optimal
metabolic control are justified on quality of life grounds as
well as clinical grounds. This however needs to be recon-
ciled with the seemingly conflicting finding that dietary re-
strictions, an important aspect of maintaining optimal
metabolic control, has such an adverse impact on diabetes-
specific quality of life. Rubin and Peyrot (1999) point out
that it seems reasonable to conclude that the benefits of
good glycaemic control offset the constraints or burden
imposed by the more demanding self-care regimen re-
quired to maintain it especially in the longer-term. Alterna-
tively, “current” glycaemic control may simply serve as a
marker of mental health and thus the ability to maintain
“current” good control [25,29]. This should not be
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be expected to correlate with better health outcomes, in-
cluding quality of life. It seems reasonable to conclude that
while mental health issues (such as depression) may inter-
fere with effective diabetes self-management, and lead to
deterioration in glycaemic control [30], at the same time,
good control of diabetes over the longer-term cumulatively
leads to better quality of life measures [3]. Future studies
need to take into account this distinction between current
glycaemic status and prior glycaemic control.
The direction of the age effect was unexpectedly in
favour of older age such that it was associated with better
diabetes-specific quality of life. Satisfaction with family life,
vocational and financial situations improve with age [31]
and perhaps expectations decline with age too. This lower-
ing of expectations may be an important mechanism by
which older adults maintain satisfaction with their lives or
certain aspects of their lives despite declining health. Al-
ternatively, as there is generally an increased prevalence of
health conditions amongst older persons, society may pro-
vide greater support for adjusting to living with diabetes
for older people than it does for younger people with dia-
betes, whose social networks may provide fewer opportun-
ities for social support.
This study has both strengths and limitations. There
are few studies designed to explore how diabetes impacts
on the lives of people living with type 2 diabetes with a
sample size of the magnitude and representativeness of
the Living with Diabetes Study. For example, we have
found no previous study with adequate statistical power
to confirm the association between individual diabetes
complications and diabetes-specific quality of life after
controlling for important covariates. Findings are how-
ever limited by the fact that complications and comorbid
diagnoses were self-reported and therefore reliant on re-
call. The presence of some comorbidities were likely (e.
g. mental health disorders, substance abuse) or almost
certainly (e.g. dementia) to be underreported by the pa-
tients. Furthermore, patients were asked whether a doc-
tor or nurse had ever told them that they had any of a
predefined list of comorbid conditions. While these con-
ditions were for the most part chronic in nature, it is
possible that in some cases the condition may not have
had any current bearing on the patient, for example hav-
ing suffered from asthma as a child, or having been suc-
cessfully treated for cancer many years ago. Also, an
overlap between quality of life measures and measures
of depressive symptomatology has been noted [32]. Yet
in the current study this effect will be attenuated by our
use of a diabetes-specific measure of quality of life that
has less commonality of items that measure depression
than for example a health-related quality of life measure.
Finally, the response rate for participants consenting
to participate in the research was low, yet consistent withresearch showing that participation rates in large cohort
studies appear to be declining [33]. In a detailed analysis of
respondents versus non-respondents, it was shown that in-
dividuals were less likely to participate in the Living with
Diabetes Study if they were younger or older than those
aged 50 to 69 years or had identified themselves as being
Aboriginal or Torres Strait Islander Australians, whereas
there was no difference in relation to gender, length of time
since diagnosis or socio-economic status [16]. David and
colleagues (2011) observed that when disease registers are
used to recruit patients, the generalizability of a study’s find-
ings to the target population is very much dependent on
register coverage and the quality of its database. Given the
coverage of the NDSS is estimated to be between 80% and
90%, which is higher than most diabetes registers, it has the
potential to produce sampling frames of a higher data qual-
ity than most.
Conclusions
The findings from this large cohort study about diabetes-
specific quality of life have important implications for the
care of those with type 2 diabetes. In particular, complica-
tions and poor glycaemic control independently serve to
decrease diabetes-specific quality of life. While dietary
control and the prevention of complications, for example,
are important aspects of the management of the condi-
tion, loss of the freedom to eat as desired was the most
negatively affected aspect of quality of life among the
study participants. This creates something of a dilemma
for health care providers in that they need to educate pa-
tients about the longer-term link between healthful eating,
better glycaemic control and reduced risk of diabetes com-
plications yet an over-emphasis on the need for healthful
eating may impede quality of life. Mental health issues also
need to be addressed as they were an important contribu-
tor to decreased diabetes-specific quality of life. Finally,
comorbidities seem to play a much smaller role and in-
deed cancer survivors may even paradoxically have better
diabetes-specific quality of life. Since a focus on glycaemic
control and complications is already a routine aspect of
diabetes care, improvement in mental health care can go a
long way towards increasing diabetes-specific quality of
life in these populations.
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